Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and in vitro validation in HeLa cells
暂无分享,去创建一个
[1] N. Anderson,et al. Electrometric and colorimetric determination of carbonic anhydrase. , 1948, The Anatomical record.
[2] J. Hirose,et al. [Carbonic anhydrase]. , 1983, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[3] R. Kettmann,et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.
[4] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[5] B. Jonsson,et al. The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. , 1997, European journal of biochemistry.
[6] G N Shah,et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Pastorek,et al. Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion , 2000, British Journal of Cancer.
[8] M. Lerman,et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.
[9] W. Sly,et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.
[10] J. Pastorek,et al. Biodistribution and pharmacokinetics of 125I‐labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma , 2003, International journal of cancer.
[11] J. Závada,et al. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment. , 2005, Oncology reports.
[12] Richard A. Friesner,et al. Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..
[13] J. Pastorek,et al. Cancer-associated carbonic anhydrases and their inhibition. , 2008, Current pharmaceutical design.
[14] A. Scaloni,et al. Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes* , 2008, Journal of Biological Chemistry.
[15] V. Král,et al. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X‐ray crystallography, microcalorimetry, and molecular dynamics simulations , 2007, Proteins.
[16] A. Harris,et al. Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths* , 2008, Journal of Biological Chemistry.
[17] Claudiu T. Supuran,et al. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.
[18] B. Wouters,et al. Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associated with reduced survival in an acidic microenvironment. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] K. Soliman,et al. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells , 2010, Cell Biology and Toxicology.
[20] J. Pouysségur,et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. , 2009, Cancer research.
[21] C. Supuran,et al. Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells , 2010, Journal of Pharmacology and Experimental Therapeutics.
[22] A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology , 2010, PloS one.
[23] Nir London,et al. Can self‐inhibitory peptides be derived from the interfaces of globular protein–protein interactions? , 2010, Proteins.
[24] W. Sherman,et al. Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis , 2010, Chemical biology & drug design.
[25] Holger Gohlke,et al. DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein–protein interactions , 2010, Nucleic Acids Res..
[26] S. Rho,et al. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion , 2011, Journal of Cell Science.
[27] Claudiu T. Supuran,et al. Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.
[28] Vetrivel Umashankar,et al. In Silico Tools for Molecular Modeling , 2011 .
[29] P. Lambin,et al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Claudiu T. Supuran,et al. Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics , 2012, Oncotarget.
[31] Kumardeep Chaudhary,et al. Cell Penetrating Peptides , 2016 .
[32] M. Rossi,et al. Biochemical properties of a novel and highly thermostable bacterial α-carbonic anhydrase from Sulfurihydrogenibium yellowstonense YO3AOP1 , 2012, Journal of enzyme inhibition and medicinal chemistry.
[33] Caroline Louis-Jeune,et al. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra , 2012, Proteins.
[34] Brian D. Weitzner,et al. Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE) , 2013, PloS one.
[35] G. Lin,et al. The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo , 2014, International journal of molecular sciences.
[36] Kumardeep Chaudhary,et al. Computer-Aided Virtual Screening and Designing of Cell-Penetrating Peptides. , 2015, Methods in molecular biology.
[37] Kumardeep Chaudhary,et al. PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues , 2015, Biology Direct.
[38] Chundi Vinay Kumar,et al. Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6 , 2015, Journal of biomolecular structure & dynamics.
[39] P. R. Deepa,et al. Comparative Modeling and Molecular Dynamics Simulation of Substrate Binding in Human Fatty Acid Synthase: Enoyl Reductase and β-Ketoacyl Reductase Catalytic Domains , 2015, Genomics & informatics.
[40] R. Purohit,et al. Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K) , 2016, Journal of biomolecular structure & dynamics.
[41] C. Supuran. Structure and function of carbonic anhydrases. , 2016, The Biochemical journal.
[42] R. Purohit,et al. Impact of point mutation P29S in RAC1 on tumorigenesis , 2016, Tumor Biology.
[43] Sergey Lyskov,et al. Peptiderive server: derive peptide inhibitors from protein–protein interactions , 2016, Nucleic Acids Res..
[44] Muthukumaran Sivashanmugam,et al. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads , 2017, Journal of biomolecular structure & dynamics.
[45] Chandrasekhar Gopalakrishnan,et al. Pathological role of a point mutation (T315I) in BCR‐ABL1 protein—A computational insight , 2018, Journal of cellular biochemistry.
[46] B. Mahon,et al. Carbonic Anhydrases: Role in pH Control and Cancer , 2018, Metabolites.
[47] Umashankar Vetrivel,et al. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach , 2018, Life sciences.
[48] Anupriya Sadhasivam,et al. Identification of potential drugs targeting L,L‐diaminopimelate aminotransferase of Chlamydia trachomatis: An integrative pharmacoinformatics approach , 2018, Journal of cellular biochemistry.
[49] C. Supuran. Carbonic Anhydrases and Metabolism , 2018, Metabolites.
[50] Umashankar Vetrivel,et al. Design of inhibitory peptide targeting Toxoplasma gondii RON4‐human β‐tubulin interactions by implementing structural bioinformatics methods , 2018, Journal of cellular biochemistry.
[51] Hemavathy Nagarajan,et al. Demystifying the pH dependent conformational changes of human heparanase pertaining to structure–function relationships: an in silico approach , 2018, Journal of Computer-Aided Molecular Design.
[52] R. Purohit,et al. Gain of native conformation of Aurora A S155R mutant by small molecules , 2019, Journal of cellular biochemistry.
[53] Activation and inhibition effects of some natural products on human cytosolic CAI and CAII , 2019, Medicinal Chemistry Research.